Mahanta et al. (2024) [116] designed and tested mannose-functionalized chitosan-coated PLGA NPs (CHTMAN-PLGA-CBD) to enable the targeted delivery of cannabidiol (CBD) and brain-derived neurotrophic factor (BDNF) to the brain for treating AD. Here, BDNF is linked to Alzheimer disease.